We are live on ! Find out more
PAS

Point72 Asia (Singapore) Portfolio holdings

AUM $646M
1-Year Est. Return 35.24%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+35.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$532M
AUM Growth
+$52M
Cap. Flow
+$25.2M
Cap. Flow %
4.73%
Top 10 Hldgs %
35.77%
Holding
1,414
New
404
Increased
239
Reduced
267
Closed
497

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.5M
2
AVGO icon
Broadcom
AVGO
+$19.5M
3
RTX icon
RTX Corp
RTX
+$13.2M
4
ICLR icon
Icon
ICLR
+$10.9M
5
COP icon
ConocoPhillips
COP
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 25.5%
2 Communication Services 16.83%
3 Healthcare 13.7%
4 Financials 12.94%
5 Industrials 10.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDSX icon
826
Biodesix
BDSX
$248M
$18.3K ﹤0.01%
+514
New +$17.7K
CUE icon
827
Cue Biopharma
CUE
$107M
$18.2K ﹤0.01%
803
-965
-55% -$20.9K
USAS
828
Americas Gold and Silver
USAS
$1.73B
$17.8K ﹤0.01%
23,236
-1,487
-6% -$952
SB icon
829
Safe Bulkers
SB
$740M
$17.4K ﹤0.01%
3,359
+1,938
+136% +$9.96K
NLY icon
830
Annaly Capital Management
NLY
$17.4B
$17.4K ﹤0.01%
+866
New +$17.3K
DH icon
831
Definitive Healthcare
DH
$68.6M
$17.4K ﹤0.01%
+3,883
New +$18.2K
OFLX icon
832
Omega Flex
OFLX
$305M
$17.2K ﹤0.01%
+345
New +$17K
ALXO icon
833
ALX Oncology
ALXO
$272M
$17.1K ﹤0.01%
+9,369
New +$34.8K
NGG icon
834
National Grid
NGG
$80.7B
$16.7K ﹤0.01%
+255
New +$15.6K
CMBM
835
DELISTED
Cambium Networks
CMBM
$16.5K ﹤0.01%
9,025
-9,585
-52% -$18.1K
OKUR
836
OnKure Therapeutics
OKUR
$163M
$16.4K ﹤0.01%
967
-836
-46% -$12.4K
MGX icon
837
Metagenomi Therapeutics
MGX
$46.7M
$16.1K ﹤0.01%
+7,415
New +$25.7K
ZVIA icon
838
Zevia
ZVIA
$107M
$16.1K ﹤0.01%
14,880
-24,150
-62% -$22.9K
DXC icon
839
DXC Technology
DXC
$1.72B
$16K ﹤0.01%
+773
New +$15.4K
GTN icon
840
Gray Television
GTN
$494M
$16K ﹤0.01%
+2,988
New +$15.4K
SMXT icon
841
Solarmax Technology
SMXT
$19.9M
$16K ﹤0.01%
+25,325
New +$66.7K
OSG
842
Octave Specialty Group
OSG
$206M
$16K ﹤0.01%
+1,426
New +$16.7K
HMN icon
843
Horace Mann Educators
HMN
$2.13B
$15.9K ﹤0.01%
455
-1,034
-69% -$35.3K
KYNB
844
Kyntra Bio
KYNB
$28.9M
$15.4K ﹤0.01%
1,539
-4,276
-74% -$64.5K
RGR icon
845
Sturm, Ruger & Co
RGR
$596M
$15.3K ﹤0.01%
367
-2,753
-88% -$116K
BTI icon
846
British American Tobacco
BTI
$123B
$15.1K ﹤0.01%
+414
New +$14.8K
BKH icon
847
Black Hills Corp
BKH
$5.59B
$14.5K ﹤0.01%
237
-653
-73% -$38.1K
CMCO icon
848
Columbus McKinnon
CMCO
$562M
$14.2K ﹤0.01%
395
-307
-44% -$10.4K
MRTN icon
849
Marten Transport
MRTN
$1.19B
$13.8K ﹤0.01%
+780
New +$13.7K
AVPT icon
850
AvePoint
AVPT
$2.74B
$13.4K ﹤0.01%
1,142
-23,605
-95% -$259K

Similar funds

Point72 Asia (Singapore)'s Q3 2024 Portfolio in Review

As of Q3 2024, Point72 Asia (Singapore) held 1,414 positions worth $532M, up 11% from $480M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Point72 Asia (Singapore) deployed $25.2M of net new capital in Q3 2024, opening 404 new positions and adding to 239 existing holdings. Its largest new stake was Meta Platforms (Facebook): 45,704 shares worth $26.2M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was RTX Corp, an estimated $13.2M trimmed.

  • Point72 Asia (Singapore)'s largest Q3 2024 buy was Meta Platforms (Facebook): 45,704 shares worth $26.2M.
  • Point72 Asia (Singapore) added most to NVIDIA in Q3 2024, an estimated $33.1M increase.
  • Point72 Asia (Singapore)'s biggest Q3 2024 reduction was RTX Corp, cutting an estimated $13.2M.
  • Point72 Asia (Singapore) fully exited Apple in Q3 2024, selling an estimated $22.5M.
  • Point72 Asia (Singapore)'s ten largest holdings make up 36% of its $532M portfolio in Q3 2024.
  • Point72 Asia (Singapore) opened 404 new positions and closed 497 in Q3 2024.
  • Point72 Asia (Singapore)'s portfolio value rose 11% quarter-over-quarter to $532M.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2024, filed 14 Nov 2024.